The efficacy and safety of ‘assisted dying’ prescription drugs are at the moment difficult to assess. A single cause for this is usually that, in jurisdictions in which ‘assisted dying’ is practiced, clinician reporting is frequently really reduced. In Belgium, it's believed that 52% of euthanasia situations are claimed into the Federal Eut